Firefly Neuroscience, Inc.
AIFF- Exchange
- Nasdaq
- Industry
- Services-Prepackaged Software
- SEC CIK
- 0000803578
No open-market purchases or sales by Firefly Neuroscience, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.96M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Firefly Neuroscience, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 10 | 9 | −1 |
| Shares | 80.9K | 129.3K | +48.4K (+59.9%) |
| Value | $167.3K | $393.1K | +$225.8K (+135.0%) |
New holders (2)
Institutions that held Firefly Neuroscience, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 56,934 | $173.1K | 0.00% |
| Wexford Capital LP | 961 | $2.92K | 0.00% |
Sold out (3)
Institutions that held Firefly Neuroscience, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Trueblood Wealth Management, LLC | 16,000 | $33.1K |
| Vanguard Group Inc | 11,093 | $23.0K |
| UBS Group AG | 6,925 | $14.3K |